scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12031-015-0662-Y |
P698 | PubMed publication ID | 26474565 |
P2093 | author name string | Mei Zhao | |
Tingting Liu | |||
Ting Xiao | |||
Xiaoyu Sun | |||
Shanshan Zhao | |||
Jukka Jolkkonen | |||
Chuansheng Zhao | |||
Zhike Zhou | |||
P2860 | cites work | Influence of enrichment on behavioral and neurogenic effects of antidepressants in Wistar rats submitted to repeated forced swim test | Q48156397 |
Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor | Q48206434 | ||
Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery | Q48261980 | ||
Clinical trials in neuroprotection. 23-25 January 2003, Key Biscayne, FL, USA. | Q48264343 | ||
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial | Q48322937 | ||
Age effect on motor recovery in a post-acute animal stroke model | Q48325997 | ||
Forced limb-use enhanced neurogenesis and behavioral recovery after stroke in the aged rats | Q48427938 | ||
Persistent production of neurons from adult brain stem cells during recovery after stroke. | Q48739755 | ||
Outcome and time course of recovery in stroke. Part I: Outcome. The Copenhagen Stroke Study | Q49265619 | ||
Effects-of fluoxetine on sensorimotor and spatial learning deficits following focal cerebral ischemia in rats. | Q52131436 | ||
The influence of gender and age on disability following ischemic stroke: the Framingham study | Q57745337 | ||
Prevalence of Stroke and Stroke-Related Disability | Q58044576 | ||
Treatment issues in poststroke depression | Q77533906 | ||
Motor and functional recovery in patients with post-stroke depression | Q81638739 | ||
Fluoxetine enhanced neurogenesis is not translated to functional outcome in stroke rats | Q85637616 | ||
Ageing and the brain | Q24649729 | ||
Stroke | Q28279570 | ||
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
Identification of ischemic regions in a rat model of stroke | Q33416428 | ||
Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy | Q34062866 | ||
Aberrant neurogenesis after stroke: a retroviral cell labeling study. | Q34319061 | ||
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. | Q34357875 | ||
Fluoxetine targets early progenitor cells in the adult brain | Q34611258 | ||
Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice. | Q34692834 | ||
Relation between depression after stroke, antidepressant therapy, and functional recovery. | Q35463491 | ||
Effect of antidepressants on the course of disability following stroke | Q36590600 | ||
The response of the aged brain to stroke: too much, too soon? | Q36907379 | ||
Perturbed cellular response to brain injury during aging | Q37629964 | ||
Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery | Q38101167 | ||
Influence of common drugs and related factors on stroke outcome. | Q40904847 | ||
Use-dependent structural events in recovery of function | Q41261889 | ||
Cerebrovascular disorders: role of aging | Q41857957 | ||
Rescuing neurons from trans-synaptic degeneration after brain damage: helpful, harmful, or neutral in recovery of function? | Q42001638 | ||
Prominent decline of newborn cell proliferation, differentiation, and apoptosis in the aging dentate gyrus, in absence of an age-related hypothalamus-pituitary-adrenal axis activation | Q42461091 | ||
Ischemia-induced neurogenesis is preserved but reduced in the aged rodent brain | Q42471120 | ||
Stroke-induced neurogenesis in aged brain | Q42480928 | ||
Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke | Q43836504 | ||
Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. | Q43850189 | ||
Effects of fluoxetine on the 5-HT1A receptor and recovery of cognitive function after traumatic brain injury in rats | Q43966446 | ||
Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine | Q44510659 | ||
Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice | Q44526579 | ||
Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. | Q44770129 | ||
Effects of chronic fluoxetine in animal models of anxiety and depression. | Q44845253 | ||
Impact of age and caloric restriction on neurogenesis in the dentate gyrus of C57BL/6 mice | Q44880819 | ||
Influence of age on stroke outcome following transient focal ischemia | Q44914785 | ||
Seizure-associated, aberrant neurogenesis in adult rats characterized with retrovirus-mediated cell labeling. | Q44972977 | ||
Constraint-induced movement therapy overcomes the intrinsic axonal growth-inhibitory signals in stroke rats | Q44978917 | ||
Effect of cholinergic medication, before and after focal photothrombotic ischemic cortical injury, on histological and functional outcome in aged and young adult rats | Q45098671 | ||
Ageing abolishes the effects of fluoxetine on neurogenesis | Q45734792 | ||
Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke | Q46423369 | ||
Fluoxetine and recovery of motor function after focal ischemia in rats | Q46464815 | ||
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal | Q46649293 | ||
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. | Q46767739 | ||
Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice | Q46802984 | ||
Restoring production of hippocampal neurons in old age. | Q48107293 | ||
The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register | Q48144747 | ||
P433 | issue | 2 | |
P921 | main subject | fluoxetine | Q422244 |
neurogenesis | Q1456827 | ||
P304 | page(s) | 233-242 | |
P577 | publication date | 2015-10-16 | |
P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
P1476 | title | Fluoxetine Enhances Neurogenesis in Aged Rats with Cortical Infarcts, but This is not Reflected in a Behavioral Recovery. | |
P478 | volume | 58 |
Q92112193 | Antidepressant pharmacotherapy and poststroke motor rehabilitation: A review of neurophysiologic mechanisms and clinical relevance |
Q91864300 | Effects of CXCR7-neutralizing antibody on neurogenesis in the hippocampal dentate gyrus and cognitive function in the chronic phase of cerebral ischemia |
Q34680745 | NSI-189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats |
Q47783283 | Neuroplasticity and behavioral effects of fluoxetine after experimental stroke |
Q88405456 | Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults |
Q47712203 | Present Status and Future Challenges of New Therapeutic Targets in Preclinical Models of Stroke in Aged Animals with/without Comorbidities |
Q38783958 | Translational Hurdles in Stroke Recovery Studies |
Q37109496 | Up-regulation of serotonin receptor 2B mRNA and protein in the peri-infarcted area of aged rats and stroke patients |
Search more.